BioNTech Reaches $1.26 Billion Settlement Over COVID-19 Vaccine Royalties
28 December 2024
Health
Washington, U.S. – BioNTech (22UAy.DE), the German biotech firm that developed a COVID-19 vaccine in partnership with Pfizer (PFE.N), has resolved royalty disputes with the U.S. National Institutes of …